These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 7753456

  • 21. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR.
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [Abstract] [Full Text] [Related]

  • 22. How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective.
    Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K, RCPA QAP in Haematology.
    Lab Hematol; 2005 Jan; 11(3):157-62. PubMed ID: 16174600
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
    Harenberg J, Stehle G, Dempfle CE, von Hodenberg E, Heene DL.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Jan; 116(6):967-80. PubMed ID: 2483715
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P.
    Thromb Res; 2007 Jan; 120(3):347-51. PubMed ID: 17118432
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women.
    Harenberg J, Schneider D, Heilmann L, Wolf H.
    Haemostasis; 1993 Jan; 23(6):314-20. PubMed ID: 8034237
    [Abstract] [Full Text] [Related]

  • 30. [Low molecular weight heparin (CY 222) levels during hemodialysis sessions. Comparison of various chromogenic and chronometric methods. Problem of standardization].
    Roussel B, Dieval J, Bayrou B, Delobel J.
    J Mal Vasc; 1987 Jan; 12 Suppl B():85-9. PubMed ID: 2834499
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S, Canivet E, Wuillai A, Maheut H, Randoux C, Bonnet JM, Renaux JL, Chanard J.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [Abstract] [Full Text] [Related]

  • 33. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD, Lakhani M, El Rouby S, Cavusoglu E.
    J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Use of low molecular-weight heparin in hemodialysis patients].
    Schrader J, Rieger J, Müschen H, Stibbe W, Köstering H, Kramer P, Scheler F.
    Klin Wochenschr; 1985 Jan 15; 63(2):49-55. PubMed ID: 3981950
    [Abstract] [Full Text] [Related]

  • 37. Use of low-dose low molecular weight heparin in hemodialysis.
    Lai KN, Wang AY, Ho K, Szeto CC, Li M, Wong LK, Yu AW.
    Am J Kidney Dis; 1996 Nov 15; 28(5):721-6. PubMed ID: 9158210
    [Abstract] [Full Text] [Related]

  • 38. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Nov 15; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anti-factor Xa determination in blood: a new method for controlling heparin therapy.
    Harenberg J, Haaf B, Schäfer M, Dempfle CE, Stehle G, Heene DL.
    Semin Thromb Hemost; 1993 Nov 15; 19 Suppl 1():79-85. PubMed ID: 8395736
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.